Type of Study:
This is a study of medication used with patients diagnosed with endometriosis.

Study Length:

Target Age/Sex:
18 to 49 years old - Female

Participants will receive at no cost: Study medication and study related procedures and may also receive a stipend for time/travel related to the study.

Link: ClinicalTrials.gov

Staus: Enrolling


Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain.

To learn more, fill out the form or call 208-557-2924 or 208-557-2991.

Information Request

Information Request

How did you hear about this study?